Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

The US FDA List of Drugs Not to Be Used in Compounded Medications for Humans (the "Negative List")

Author(s):  Allen Loyd V Jr, Ashworth Lisa D

Issue:  Jan/Feb 2005 - Sterile Preparations
View All Articles in Issue

Page(s):  44-46

The US FDA List of Drugs Not to Be Used in Compounded Medications for Humans (the
The US FDA List of Drugs Not to Be Used in Compounded Medications for Humans (the
The US FDA List of Drugs Not to Be Used in Compounded Medications for Humans (the

Download in electronic PDF format for $65

Abstract:  The Food and Drug Modernization Act of 1997 included a provision that the Food and Drug Administration (FDA) compile a list of drugs not to be compounded for humans for reasons of safety. This list came to be called the “negative list.” The list of 59 drugs was published in the Federal Register on March 8, 1999, with the intent that the list would be updated and published regularly. Although the compounding provisions in the Modernization Act were struck down in 2002, it can be argued that the list is still enforceable by the FDA, since it is included in the Compliance Policy Guidelines (CPG) of the Center for Drug Evaluation and Research (CDER). Confusingly, however, in its 2003 Report to the Nation, a different set of “safety-based withdrawals” appears.

Related Keywords: Loyd V. Allen, Jr, PhD, RPh, Lisa D. Ashworth, RPh, Food and Drug Administration, FDA, withdrawn drugs, discontinued drugs, Center for Drug Evaluation and Research, CDER, Compliance Policy Guidelines, CPGs, drug safety

Related Categories: LEGAL, DISCONTINUED FORMULATIONS, FDA

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines
Allen Loyd V Jr
Jul/Aug 2016
Pg. 351

View Sample
The US FDA List of Drugs Not to Be Used in Compounded Medications for Humans (the "Negative List")
Allen Loyd V Jr
, Ashworth Lisa D
Jan/Feb 2005
Pg. 44-46

PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs
Allen Loyd V Jr
Sep/Oct 2017
Pg. 356

Drug Shortages & Discontinued Drugs: The Effects on Patients and Healthcare Providers
Allen Loyd V Jr
, Williams LaVonn A
Jul/Aug 2012
Pg. 294-298

U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs
Allen Loyd V Jr
Nov/Dec 2015
Pg. 487-488

PreScription: Discontinued Drugs and Drug Shortages
Allen Loyd V Jr
Mar/Apr 2011
Pg. 92

U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances
Miller David G
Jul/Aug 2015
Pg. 303-305

Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs
Dillon L R
Jan/Feb 2020
Pg. 30-36

PostScription: Drug Shortages and Discontinued Drugs: Their Effects on Healthcare
Allen Loyd V Jr
, Williams LaVonn A
Jul/Aug 2012
Pg. 350-351

Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh
Allen Loyd V Jr
Nov/Dec 2003
Pg. 449-450